Literature DB >> 18538369

Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.

Alexander S Parker1, Christine M Lohse, Bradley C Leibovich, John C Cheville, Yuri M Sheinin, Eugene D Kwon.   

Abstract

We previously used quantitative digital image analysis to report that high immunohistochemical tumor expression levels of survivin independently predict poor outcome among patients with clear cell renal cell carcinoma. However, given the cumbersome and costly nature of digital image analysis, we evaluated simple visual assessment as an alternative to digital image analysis for assessing survivin as a predictor of clear cell renal cell carcinoma patient outcomes. We identified 310 patients treated surgically for unilateral, sporadic, clear cell renal cell carcinoma at our institution between 1990 and 1994. Survivin expression was quantified independently by digital image analysis and visual assessment in paraffin slides using a commercially available antibody. We examined the agreement between the 2 methods using the kappa statistic and then used Cox regression to compare the ability of the 2 methods to predict renal cell carcinoma death. The kappa statistic comparing high survivin expression determined by digital image analysis versus visual assessment was .68, indicating substantial agreement between the 2 methods. Moreover, even after multivariate adjustment, the association of high survivin expression with risk of renal cell carcinoma death was similar for both visual assessment (risk ratio = 2.01; 95% confidence interval, 1.26-3.22) and digital image analysis (risk ratio = 1.75; 95% confidence interval, 1.10-2.80). Finally, among patients with "moderate risk" (Stage, Size, Grade, and Necrosis scores 3-6) and "high risk" (Stage, Size, Grade, and Necrosis scores 7 or greater) clear cell renal cell carcinoma, high survivin expression determined by visual assessment was significantly associated with poorer survival (P = .006 and P = .017, respectively). Herein, we demonstrate substantial agreement between survivin quantification by digital image analysis and visual assessment. We further confirm that high survivin expression assessed by visual assessment remains an independent predictor of aggressive clear cell renal cell carcinoma behavior. Thus, visual assessment represents an economical, widely available, and reliable method to assess survivin as a predictor of clear cell renal cell carcinoma patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538369      PMCID: PMC2789391          DOI: 10.1016/j.humpath.2007.12.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  23 in total

Review 1.  What brown cannot do for you.

Authors:  David L Rimm
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

Review 2.  Immunohistochemistry and quantitative analysis of protein expression.

Authors:  Melissa Cregger; Aaron J Berger; David L Rimm
Journal:  Arch Pathol Lab Med       Date:  2006-07       Impact factor: 5.534

Review 3.  Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

Authors:  R A Walker
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

Review 4.  Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Authors:  Michael B Atkins; Marc S Ernstoff; Robert A Figlin; Keith T Flaherty; Daniel J George; William G Kaelin; Eugene D Kwon; Towia A Libermann; W Marston Linehan; David F McDermott; Augusto C Ochoa; Allan J Pantuck; Brian I Rini; Mark A Rosen; Jeffrey A Sosman; Vikas P Sukhatme; Johannes W Vieweg; Christopher G Wood; Laura King
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 5.  Translational crossroads for biomarkers.

Authors:  Robert C Bast; Hans Lilja; Nicole Urban; David L Rimm; Herbert Fritsche; Joe Gray; Robert Veltri; George Klee; Andrew Allen; Nam Kim; Steven Gutman; Mark A Rubin; Andrew Hruszkewycz
Journal:  Clin Cancer Res       Date:  2005-09-01       Impact factor: 12.531

6.  Improved prognostication of renal cell carcinoma using an integrated staging system.

Authors:  A Zisman; A J Pantuck; F Dorey; J W Said; O Shvarts; D Quintana; B J Gitlitz; J B deKernion; R A Figlin; A S Belldegrun
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

7.  Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

Authors:  Shomik Sengupta; Christine M Lohse; Bradley C Leibovich; Igor Frank; R Houston Thompson; W Scott Webster; Horst Zincke; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

8.  The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program.

Authors:  Mike M Nguyen; Inderbir S Gill; Lars M Ellison
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

Review 9.  Staging of renal cell carcinoma: past, present, and future.

Authors:  Carvell T Nguyen; Steven C Campbell
Journal:  Clin Genitourin Cancer       Date:  2006-12       Impact factor: 2.872

Review 10.  Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.

Authors:  A M Verhagen; E J Coulson; D L Vaux
Journal:  Genome Biol       Date:  2001-07-05       Impact factor: 13.583

View more
  8 in total

1.  Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma.

Authors:  Sulai Liu; Lin Qi; Qiuxia Yu; Yinghui Song; Weiqing Han; Xiongbing Zu; Shusuan Jiang; Jinyang Yuan; Fuhua Zeng; Yu Xie
Journal:  Tumour Biol       Date:  2014-05-23

Review 2.  Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review.

Authors:  Keerthana Prasad; Gopalakrishna K Prabhu
Journal:  J Med Syst       Date:  2011-05-17       Impact factor: 4.460

3.  Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Bradley C Leibovich; Christine M Lohse; Yuri Sheinin; Susan M Kuntz; Jeanette E Eckel-Passow; Michael L Blute; Eugene D Kwon
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

4.  Tissue microarrays: one size does not fit all.

Authors:  Jeanette E Eckel-Passow; Christine M Lohse; Yuri Sheinin; Paul L Crispen; Christopher J Krco; Eugene D Kwon
Journal:  Diagn Pathol       Date:  2010-07-07       Impact factor: 2.644

5.  Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.

Authors:  Anthony E Rizzardi; Xiaotun Zhang; Rachel Isaksson Vogel; Suzanne Kolb; Milan S Geybels; Yuet-Kin Leung; Jonathan C Henriksen; Shuk-Mei Ho; Julianna Kwak; Janet L Stanford; Stephen C Schmechel
Journal:  Diagn Pathol       Date:  2016-07-11       Impact factor: 2.644

6.  Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.

Authors:  Zhichen Pu; Qifei Wang; Haitang Xie; Guangji Wang; Haiping Hao
Journal:  Oncotarget       Date:  2017-03-21

7.  Single-cell RNA sequencing reveals differential cell cycle activity in key cell populations during nephrogenesis.

Authors:  Abha S Bais; Débora M Cerqueira; Andrew Clugston; Andrew J Bodnar; Jacqueline Ho; Dennis Kostka
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

8.  Immunohistochemical detection of angiotensin AT 1 and AT 2 receptors in prostate cancer.

Authors:  Marek Pawlikowski; Radosław Minias; Marek Sosnowski; Krzysztof W Zieliński
Journal:  Cent European J Urol       Date:  2011-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.